{"id":"NCT00767624","sponsor":"Stanford University","briefTitle":"TRIAD - Treatment of Insomnia and Depression","officialTitle":"Improving Depression Outcome by Adding Insomnia Therapy to Antidepressants","status":"COMPLETED","phase":"PHASE2","dates":{"start":"2008-12","primaryCompletion":"2015-06","completion":"2015-06","firstPosted":"2008-10-07","resultsPosted":"2016-12-05","lastUpdate":"2016-12-05"},"enrollment":150,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"TRIPLE","primaryPurpose":"TREATMENT"},"conditions":["Sleep Initiation and Maintenance Disorders","Depression"],"interventions":[{"type":"DRUG","name":"Antidepressant","otherNames":[]},{"type":"BEHAVIORAL","name":"Desensitization Therapy for Insomnia","otherNames":[]},{"type":"BEHAVIORAL","name":"Cognitive Behavioral Therapy for Insomnia","otherNames":[]}],"arms":[{"label":"antidepressant + desensitization","type":"OTHER"},{"label":"antidepressant + cognitive behavioral","type":"OTHER"}],"summary":"The aim of the proposed three-site study is to increase the rate of full remission from major depressive disorder (MDD) at the end of 16 weeks of treatment for people who experience both major depressive disorder and insomnia.","primaryOutcome":{"measure":"Percent of Participants With Depression Remission","timeFrame":"16 weeks","effectByArm":[{"arm":"Antidepressant + Desensitization","deltaMin":36,"sd":null},{"arm":"Antidepressant + Cognitive Behavioral","deltaMin":43.8,"sd":null}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":3,"countries":["United States"]},"refs":{"pmids":["38183804","36798983","30952216","29504795","27788313"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":3,"n":75},"commonTop":["Medically significant event not requiring hospitalization"]}}